Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 26, 2023

Primary Completion Date

February 1, 2024

Study Completion Date

February 1, 2024

Conditions

Multiple Sclerosis

Interventions

DRUG

PIPE-791

Single and multiple ascending oral doses of PIPE-791 tablets.

DRUG

Placebo

Single and multiple ascending oral doses of matching placebo tablets.

Trial Locations (1)

Worldwide Clinical Trials, San Antonio